Hainan Huluwa Pharmaceutical Co., Ltd. (605199)
Market Open
7 Aug, 06:57
SSE SSE Primary ¥
6. 03
+0.02
+0.3328%
¥
6.77B Market Cap
- P/E Ratio
0.5% Div Yield
1.86M Volume
- Eps
¥ 6.01
Previous Close Want to track 605199 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
605199 trading today higher at ¥6.03, an increase of 0.3328% from yesterday's close, completing a monthly increase of 15.739% or ¥0.82. Over the past 12 months, 605199 stock lost -20.1325%.
605199 is not paying dividends to its shareholders.
The last earnings report, released on May 22, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
605199 Chart
People also search for
Hainan Huluwa Pharmaceutical Co., Ltd. (605199) FAQ
What is the stock price today?
The current price is ¥6.03.
On which exchange is it traded?
Hainan Huluwa Pharmaceutical Co., Ltd. is listed on SSE.
What is its stock symbol?
The ticker symbol is 605199.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.5%.
What is its market cap?
As of today, the market cap is 6.77B.
Has Hainan Huluwa Pharmaceutical Co., Ltd. ever had a stock split?
No, there has never been a stock split.
Hainan Huluwa Pharmaceutical Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Ms. Jinping Liu CEO | SSE Exchange | CNE100004223 ISIN |
| CN Country | 2,468 Employees | 23 Jun 2021 Last Dividend | - Last Split | - IPO Date |
Overview
Hainan Huluwa Pharmaceutical Group Co., Ltd., established in 2005 and headquartered in Haikou, China, focuses on the research, development, production, and sale of pharmaceuticals. The company specializes in a range of therapeutic areas including Children's digestive and respiratory systems, anti-infection, anti-virus among others, catering primarily to the domestic market in China. Through its dedication to healthcare, Hainan Huluwa Pharmaceutical Group Co., Ltd. aims to provide effective medical solutions to improve patient outcomes in various medical conditions.
Products and Services
- Pediatrics: Specialized medications designed to address the health needs of children, focusing on common pediatric conditions.
- Gynecology: Drugs tailored for women's health, targeting conditions affecting the female reproductive system.
- Antibiotics: Broad range of antibacterial compounds for treating bacterial infections, crucial in both children and adults.
- Respiratory: Therapeutic solutions aimed at treating respiratory ailments such as asthma, bronchitis, and other airway conditions.
- Digestive System: Products designed to alleviate various digestive disorders, ensuring better gastrointestinal health.
- Cardiovascular and Cerebrovascular: Medications for managing and preventing diseases affecting the heart and blood vessels, addressing a leading cause of global mortality.
- Nourishment: Nutritional supplements and fortified products designed to support overall health and complement medical treatments.
Contact Information
Address: No. 8, Yaogu 4th Road, Haikou, China, 570311
Phone: 86 898 6868 9766
Website: https://www.huluwayaoye.com
